ICU Medical Inc insider trading
Every open-market purchase and sale by ICU Medical Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following ICU Medical Inc’s insiders pay?
From January 11, 2010 to August 13, 2026, 23 insiders reported 5 open-market purchases and 201 sales not made under a pre-set plan in ICU Medical Inc. Twelve months after each purchase was reported, the shares were +23.7% against the S&P 500 on average (median +30.0%), over 5 purchases with a full year of prices; 80% beat the index. After sales, the shares moved +7.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 6, 2014 into $36,773 by November 2, 2026, +10.9% a year. It held shares 29% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $18,619 (+5.0% a year), and held throughout $49,742 (+13.5%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Lopez George A | Chairman | 2 | +20.2% (2) | 50% | 57 | +2.6% (57) | March 14, 2024 |
| Costello Richard A | Vice President Sales | 0 | — | — | 19 | +6.3% (19) | February 26, 2014 |
| Swinney Robert S | Director | 0 | — | — | 18 | +28.8% (18) | September 15, 2021 |
| Burcar Alison D | Vice President and Gen'l Mgr. | 0 | — | — | 13 | +10.7% (13) | June 21, 2018 |
| Sanzone Virginia Ruth | VP, General Counsel | 0 | — | — | 12 | +1.7% (10) | May 15, 2026 |
| Voigtlander Christian B. | Chief Operating Officer | 0 | — | — | 12 | −16.6% (11) | August 11, 2026 |
| Saucedo Joseph R | Director | 0 | — | — | 8 | +18.1% (8) | May 14, 2018 |
| Woolson Daniel | VP, GM-Infusion Capital | 0 | — | — | 8 | −2.6% (5) | August 13, 2026 |
| Connors John J | Director | 0 | — | — | 7 | +15.0% (7) | February 13, 2015 |
| Jain Vivek | Chairman and CEO | 2 | +30.7% (2) | 100% | 5 | +29.4% (5) | August 14, 2025 |
| Finney Elisha W | Director | 0 | — | — | 6 | −16.2% (4) | August 11, 2026 |
| Riggs Steven | VP Operations | 0 | — | — | 6 | +26.8% (6) | December 12, 2014 |
| Lamb Scott E | Chief Financial Officer, | 0 | — | — | 5 | +30.9% (5) | December 10, 2019 |
| Greenberg David C. | Director | 1 | +16.6% (1) | 100% | 3 | −33.5% (2) | May 13, 2026 |
| Kovalchik Michael T | Director | 0 | — | — | 4 | −0.5% (4) | November 5, 2013 |
| Sherman Richard Md | Director | 0 | — | — | 4 | +22.4% (4) | March 14, 2017 |
| Brown Jack | Director | 0 | — | — | 3 | +31.6% (3) | February 18, 2015 |
| Mccall Thomas D | Vice President and Gen'l Mgr. | 0 | — | — | 3 | −3.4% (3) | August 27, 2018 |
| Sousa Ben | Chief Information Officer | 0 | — | — | 3 | −11.3% (2) | August 12, 2026 |
| Mcgrody Kevin J | Controller | 0 | — | — | 2 | −3.9% (2) | June 11, 2019 |
| C.P. Pharmaceuticals International C.V. | Director | 0 | — | — | 1 | −39.8% (1) | November 16, 2018 |
| Pfizer Production LLC | Director | 0 | — | — | 1 | −48.3% (1) | August 15, 2018 |
| Smiths Group PLC and related entities | Other | 0 | — | — | 1 | +19.7% (1) | March 1, 2024 |
When several insiders traded ICU Medical Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of ICU Medical Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged +5.7% against the index. After 17 selling crowds, +1.8%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| May 29, 2026 | 3 selling | +27.4% | not yet | not yet |
| November 28, 2025 | 3 selling | −3.7% | −23.9% | not yet |
| August 29, 2025 | 2 buying | +10.0% | +5.7% | +14.4% |
| May 30, 2025 | 4 selling | −15.1% | −6.5% | −33.6% |
| December 31, 2024 | 3 selling | −0.6% | −22.9% | −25.8% |
| March 28, 2024 | 5 selling | +6.3% | +52.6% | +19.8% |
| September 30, 2021 | 3 selling | −8.8% | −10.5% | −20.0% |
| August 31, 2020 | 3 selling | −9.8% | −8.8% | −31.6% |
| May 31, 2018 | 3 selling | −2.9% | −18.5% | −29.6% |
| November 30, 2017 | 4 selling | +12.4% | +32.9% | +6.8% |
| March 31, 2017 | 5 selling | +9.9% | +14.1% | +48.7% |
| August 31, 2016 | 3 selling | +18.5% | +9.5% | +23.6% |